Europe: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

Europe: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

 

 

European Medicines Agency
News & Press Releases
News: COVID-19: EMA recommends authorisation of two monoclonal antibody medicines (updated)
CHMP, Last updated: 12/11/2021

 

 

News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 8-11 November 2021 (new)
CHMP, Last updated: 12/11/2021

 

 

News: EMA starts evaluating use of COVID-19 vaccine Spikevax in children aged 6 to 11 (new)
CHMP, Last updated: 10/11/2021

 

 

::::::

 

European Centre for Disease Prevention and Control
https://www.ecdc.europa.eu/en
Latest Updates
Publication
Overview of the implementation of COVID-19 vaccination strategies and deployment plans in the EU/EEA
Technical report – 11 Nov 2021

News
New update of the ECDC COVID-19 Vaccine Tracker
News story – 10 Nov 2021

 

 

::::::

Accessed 13 Nov 2021
https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#uptake-tab

 

 

::::::

 

European Commission
https://ec.europa.eu/commission/presscorner/home/en
Press release 11 November 2021
European Health Union: green light for two new COVID-19 therapeutics
Today, the European Medicines Agency (EMA) has given a positive opinion on two COVID-19 treatments – Ronapreve and Regkirona – identified by the Commission as promising therapeutics under the EU Strategy on COVID-19 Therapeutics.

Press release 10 November 2021
Coronavirus: Commission approves contract with Valneva to secure a new potential vaccine
Today, the European Commission approved the eighth contract with a pharmaceutical company with a view to purchasing its potential vaccine against COVID-19. The contract with Valneva provides for the possibility for all EU Member States to purchase almost 27 million doses in 2022. It also includes the possibility to adapt the vaccine to new variant strains, and for Member States to make a further order of up to 33 million additional vaccines in 2023…